Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Adamis Pharmaceuticals Corp (NASDAQ:ADMP)

4.11
Delayed Data
As of Aug 03
 -0.0768 / -1.83%
Today’s Change
2.62
Today|||52-Week Range
7.26
-33.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization14.6K0.000.00296.1K
 
 
 
 
Operating ExpensesGross Income-14.6K0.000.00-296.1K
 
 
 
General Expenses6.2M4.8M3.2M4.1M
 
 
 
 
 
Research And Development2.9M1.9M1.2M1.0M
 
 
 
 
 
Total Operating Expenses6.2M4.8M3.2M4.4M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.2M-4.8M-3.2M-4.4M
 
 
 
 
 
Extraordinary Credit0.00----4.9M
 
 
Extraordinary Charge0.00---1.5M--
 
 
Interest Expense On Debt744.3K35.4K2.3M8.6M
 
 
 
 
 
Other Expenses5.6K5.3K0.000.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-7.0M-4.8M-7.1M-8.2M
 
 
 
 
 
Discontinued Operations0.00-70.0K-130.0K0.00
 
 
 
Net Income-7.0M-4.9M-7.2M-8.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.8M5.3M5.9M7.3M
 
 
 
 
 
Shares To Calculate EPS Diluted3.8M5.3M5.9M7.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.87-$1.02-$1.19-$1.22
 
 
 
 
 
EPS Diluted-$1.87-$0.85-$1.19-$1.22